Skip to main content
. 2016 Jun 16;6:28165. doi: 10.1038/srep28165

Table 1. Prospective studies that investigated the association of dietary and circulating EPA and/or DHA with risk of all-cause mortality.

First author, year (Country/region) Source of populations, duration Participants No. of deaths Comparison RR (95% CI) Diet assessment Adjustment for potential confounders Quality scores
Dietary intake
 Folsom, 2004 (United States) IWHS, 14yr 41 836 F aged 55–69 yr 4653 Q5 vs. Q1 0.96 (0.86–1.06) Self-reported FFQ Age, BMI, WHR, education, physical activity, smoking, age at first live birth, estrogen use, vitamin use, diabetes, hypertension, and intake of energy, alcohol, whole grains, fruit and vegetables, red meat, cholesterol, and saturated fat. 7
 Nagata, 2012 (Japan) Takayama Study, 16 yr 28 356 M/F aged ≥35 yr 2499 M; 2117 F Q5 vs. Q1 1.03 (0.86–1.23) (M) 1.04 (0.85–1.26) (F) Self-reported FFQ, validated Age, height, BMI, physical activity, smoking, education, marital status, histories of diabetes and hypertension, and intakes of energy, alcohol, protein, SFA, MUFA, non-long-chain n-3 PUFA, fruit, vegetables, fiber, and percent energy from carbohydrate in foods other than rice. 9
 Takata, 2013 (China) SMHS, 5.6 yr; SWHS, 11.2 yr 61 137 M aged 40–74 yr; 73 159 F aged 40–70 yr 2170 M; 3666 F Q5 vs. Q1 0.79 (0.72–0.87) Self-reported FFQ, validated Age, income, occupation, education, comorbidity index, physical activity, smoking, and intakes of energy, alcohol (for M), red meat, poultry, fruit, and vegetable. 8
 Miyagawa, 2014 (Japan) NIPPON DATA80, 24 yr 9190 M/F aged ≥30 yr 2551 Q5 vs. Q1 0.80 (0.66–0.96)a 0.97 (0.84–1.12)b Food records Age, sex, BMI, smoking, SBP, blood glucose, serum total cholesterol, antihypertensive medication status, residential area, intakes of alcohol SFA, n-6 PUFA, vegetable protein, total dietary fiber, and sodium. 8
 Bell, 2014 (United States) VITAL Study, 5.0 yr 70 495 M/F aged 50–76 yr 3051 Q4 vs. Q1 0.84 (0.76–0.93) Self-reported FFQ Age, sex, BMI, smoking, race/ethnicity, marital status, education, physical activity, self-rated health, mammogram in, prostate- specific antigen test, sigmoidoscopy, uses of cholesterol-lowering medication, aspirin, non-aspirin NSAIDs, estrogen, and estrogen+progestin, morbidity score, age at menopause, age at death of father or mother, and intakes of total energy and energy from trans fat and SFA, alcohol, fruit, and vegetables, 7
 Villegas, 2015 (United States) SCCS, 5.5 yr 77 100 M/F aged 40–79 yr 6917 Q5 vs. Q1 0.94 (0.86–1.03) Self-reported FFQ, validated Age, sex, BMI, smoking, physical activity, income, education, insurance coverage, race, and intakes of energy, alcohol, and total meat. 8
Circulating levels
 Warensjö, 2008 (Sweden) ULSAM, 30.7yr 1885 M aged 50 yr 1012 Per SDc increase EPA: 1.00 (0.94–1.08) DHA: 0.95 (0.89–1.02) Gas chromatography Total cholesterol, BMI, smoking, physical activity, and hypertension. 8
 Chien, 2013 (Taiwan) Residents living in Chin-Shan Township, 9.6 yr 1833 M/F aged >35 yr 568 Q4 vs. Q1 EPA: 0.77 (0.59–1.00) DHA: 0.89 (0.68–1.18) Gas chromatography Age, sex, BMI, smoking, alcohol drinking, marital status, education, occupation, sports activity, hypertension, diabetes, LDL-C and HDL-C levels. 8
 Mozaffarian, 2013 (United States) CHS 2692 M/F aged ≥65 yr 1625 Q5 vs. Q1 EPA: 0.83 (0.71–0.98) DHA: 0.80 (0.67–0.94) Gas chromatography Age, sex, BMI, WC, physical activity, race, education, enrollment site, fatty acids measurement batch, smoking, prevalent diabetes, AF, and drug- treated hypertension, and intakes of alcohol, tuna or other broiled or baked fish, fried fish, red meat, fruit, vegetables, and dietary fiber. 7
 Marklund, 2015 (Sweden) Residents living in Stockholm County, 14.5 yr 4232M/F aged 60 yr 356 Q4 vs. Q1d EPA: 0.81 (0.72–0.91) DHA: 0.75 (0.68–0.84) Gas chromatography Sex, BMI, smoking, physical activity, education, alcohol intake, diabetes mellitus, drug-treated hypertension, and drug-treated hypercholesterolemia. 8

AF, atrial fibrillation; BMI, body mass index; CHS, Cardiovascular Health Study; CVD, cardiovascular disease; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; F, females; FFQ, Food frequency questionnaire; HDL-C, high-density lipoprotein cholesterol; IWHS, Iowa Women’s Health Study; LDL-C, low-density lipoprotein cholesterol; M, males; MUFA, monounsaturated fatty acid; NSAIDs, non-aspirin nonsteroidal anti-inflammatory drugs; PUFA, polyunsaturated fatty acid; Q, quartile/quintile; SCCS, Southern Community Cohort Study; SBP, systolic blood pressure; SFA, saturated fatty acids; SMHS, Shanghai Men’s Health Study; SWHS, Shanghai Women’s Health Study; ULSAM, The Uppsala Longitudinal Study of Adult Men; WC, waist circumference; WHR, waist/hip ratio; yr, years.

aRisk estimates for total CVD mortality.

bRisk estimates for total non-CVD mortality.

cThe estimated SD was 0.52% for EPA and 0.19% for DHA, respectively.

dThis study also reported risk estimates for per SD (1% for EPA and 0.2% for DHA, respectively) increase in circulating long-chain n-3 fatty acids, and presented sex-specific results.